Legal Representation
Attorney
Scott Rogers
USPTO Deadlines
Next Deadline
700 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-06-15)
Due Date
June 15, 2027
Grace Period Ends
December 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 30, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 2, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 2, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 15, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 15, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 30, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 30, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 28, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Mar 10, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 10, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Mar 10, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 19, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 4, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 4, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 30, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 28, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 28, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 28, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 28, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 28, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 19, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 29, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 29, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 4, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 1, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 31, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 26, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 25, 2020 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Aug 20, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemical reagents for industrial and scientific purposes, other than for medical or veterinary purpose; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical additives for use in the manufacture of food, namely, for use in and preserving of foodstuffs and fodder; chemical preparations for use in marine industry, namely, for use in controlling and preventing clogging or fouling of organics
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Chemical preparations for medical, pharmaceutical or veterinary purposes, namely, for the treatment or prevention of lifestyle acquired health problems, namely, metabolic, cardiovascular, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vermin destroying preparations; fungicides; herbicides; nutritional supplements; pharmaceutical preparations and products for the prevention of lifestyle acquired health problems, namely, metabolic, cardiovascular, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceuticals for the treatment of lifestyle acquired health problems, namely, metabolic, cardiovascular, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and technological services, namely, research and design in the field of biotechnology; industrial analysis and research services in the field of biotechnology
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042